Kensuke Horio

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.

Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.

Journal: Internal medicine (Tokyo, Japan)

Published: February 22, 2021

The ideal porous structure of EDLC carbon electrodes with extremely high capacitance.

The ideal porous structure of EDLC carbon electrodes with extremely high capacitance.

Journal: Nanoscale

Published: October 11, 2017

Long-lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib.

Long-lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib.

Journal: Oncology letters

Published: September 07, 2017

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Journal: British journal of haematology

Published: August 03, 2017

Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement.

Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement.

Journal: Internal medicine (Tokyo, Japan)

Published: November 03, 2016

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Journal: Cancer science

Published: March 29, 2016

Impact of Nagasaki atomic bomb exposure on myelodysplastic syndrome patients who are treated with azacitidine.

Impact of Nagasaki atomic bomb exposure on myelodysplastic syndrome patients who are treated with azacitidine.

Journal: Anticancer research

Published: May 13, 2015

Sweet's syndrome in patients with MDS and MEFV mutations.

Sweet's syndrome in patients with MDS and MEFV mutations.

Journal: The New England journal of medicine

Published: February 12, 2015

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab.

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab.

Journal: Case reports in oncology

Published: September 19, 2014

Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.

Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.

Journal: Leukemia research

Published: August 05, 2013

Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.

Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.

Journal: The Journal of biological chemistry

Published: February 09, 2013

Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine.

Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine.

Journal: Case reports in oncology

Published: June 20, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026